Plimoth Trust’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$389K Sell
4,487
-373
-8% -$35.7K 0.09% 132
2025
Q4
$467K Sell
4,860
-3,262
-40% -$317K 0.1% 121
2025
Q3
$774K Sell
8,122
-1,266
-13% -$116K 0.18% 98
2025
Q2
$818K Sell
9,388
-326
-3% -$27.6K 0.2% 98
2025
Q1
$873K Buy
9,714
+1,101
+13% +$98.5K 0.23% 97
2024
Q4
$688K Sell
8,613
-1,985
-19% -$172K 0.18% 99
2024
Q3
$954K Sell
10,598
-3,605
-25% -$303K 0.24% 89
2024
Q2
$1.12M Sell
14,203
-9,313
-40% -$763K 0.3% 81
2024
Q1
$2.05M Sell
23,516
-8,112
-26% -$692K 0.55% 59
2023
Q4
$2.61M Sell
31,628
-800
-2% -$61K 0.75% 46
2023
Q3
$2.54M Sell
32,428
-630
-2% -$52.7K 0.8% 42
2023
Q2
$2.91M Sell
33,058
-403
-1% -$34.7K 0.87% 39
2023
Q1
$2.7M Sell
33,461
-55
-0.2% -$4.48K 0.84% 43
2022
Q4
$2.6M Buy
33,516
+568
+2% +$46K 0.84% 40
2022
Q3
$2.66M Sell
32,948
-513
-2% -$46.1K 0.92% 33
2022
Q2
$3M Sell
33,461
-1,606
-5% -$163K 0.95% 32
2022
Q1
$3.89M Buy
35,067
+733
+2% +$77.4K 1.03% 27
2021
Q4
$3.55M Buy
34,334
+1,298
+4% +$150K 0.9% 33
2021
Q3
$4.14M Buy
33,036
+59
+0.2% +$7.64K 1.17% 22
2021
Q2
$4.09M Sell
32,977
-1,169
-3% -$147K 1.15% 22
2021
Q1
$4.03M Buy
34,146
+1,668
+5% +$195K 1.19% 21
2020
Q4
$3.8M Buy
32,478
+163
+0.5% +$17.9K 1.19% 22
2020
Q3
$3.36M Buy
32,315
+2,464
+8% +$247K 1.13% 26
2020
Q2
$2.74M Buy
29,851
+14,787
+98% +$1.42M 0.97% 31
2020
Q1
$1.36M Buy
15,064
+6,481
+76% +$689K 0.57% 55
2019
Q4
$974K Sell
8,583
-22
-0.3% -$2.41K 0.32% 92
2019
Q3
$935K Sell
8,605
-952
-10% -$99.3K 0.31% 97
2019
Q2
$931K Sell
9,557
-925
-9% -$84.5K 0.31% 99
2019
Q1
$955K Buy
10,482
+592
+6% +$53K 0.32% 99
2018
Q4
$900K Sell
9,890
-28
-0.3% -$2.62K 0.33% 93
2018
Q3
$976K Sell
9,918
-690
-7% -$63.8K 0.32% 99
2018
Q2
$909K Buy
10,608
+922
+10% +$77K 0.31% 99
2018
Q1
$777K Buy
9,686
+1,160
+14% +$95.7K 0.27% 108
2017
Q4
$689K Buy
+8,526
New +$683K 0.25% 112

Other funds holding MDT

Plimoth Trust's MDT Position: Q1 2026 in Review

Plimoth Trust reduced its Medtronic (MDT) stake by 7.7% in Q1 2026, selling an estimated $35.7K and leaving 4,487 shares worth $389K. The position accounts for 0.09% of the portfolio, ranked #132.

Plimoth Trust first reported a position in MDT in Q4 2017 and has held it in 34 quarters since. The position peaked at $4.14M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Plimoth Trust held 4,487 shares of Medtronic worth $389K as of Q1 2026.
  • Plimoth Trust sold 373 Medtronic shares in Q1 2026, an estimated $35.7K.
  • Medtronic made up 0.09% of Plimoth Trust's portfolio in Q1 2026, its #132 holding.
  • Plimoth Trust first reported a position in Medtronic in Q4 2017 and has held it in 34 quarters since.
  • Plimoth Trust's Medtronic position peaked at $4.14M in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Plimoth Trust's 13F filing for Q1 2026, filed 27 Apr 2026.